Previous post Next post

Swiss pharma firm Roche acquires AI specialist PathAI

Swiss pharmaceutica giant Roche is expanding in the field of digital pathology with an agreement to acquire United States firm PathAI. +Get the most important news from Switzerland in your inbox With this acquisition, Roche aims to expand its position in AI-based diagnostic solutions. The purchase price is $750 million plus potential milestone payments of up to $300 million, the company announced. + Why Roche’s supercomputer is a big deal The combination of PathAI's AI-powered Image Management System (IMS) with Roche's diagnostic expertise is expected to increase the efficiency of laboratories, accelerate the development of new clinical therapies and enable the discovery of new biomarkers and new diagnostic tools. Roche expects this to be a further step towards personalised medicine. Roche and PathAI already entered into a collaboration in 2021, which was intensified in 2024. Roche expects the acquisition of PathAI to be completed in the second half of the current year, subject to ... Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2026/05/swiss-pharma-firm-roche-acquires-ai-specialist-pathai/

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.